Table 1 Demographic, perioperative, and outcome data
Patient | Gender | Age, years | Surgical substrate | AEDs | Lesions ablated, n | Blood loss, ml | Planned ablation volume, mm3 | Actual ablation volume, mm3 | Intersection volume, mm3 | Ablation rate | Hospital stay, days | Outcome(Engel class) | Complications | Prior surgery |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 5.4 | HH | LEV | 1 | 1 | 659.164 | 759.414 | 610.284 | 92.6% | 4 | III | None | Craniotomy |
2 | M | 4.9 | HH | OXC | 1 | 10 | 1667.92 | 1722.65 | 1537.59 | 92.2% | 4 | III | None | None |
3 | M | 6 | HH | LTG, LCM | 1 | 5 | 485.148 | 606.796 | 406.62 | 83.8% | 5 | III | None | Craniotomy |
4 | F | 6.2 | HH | LEV, OXC | 1 | 5 | 755.432 | 841.078 | 690.878 | 91.5% | 4 | I | None | RF-TC |
5 | M | 19.5 | HH | LTG, OXC | 1 | 5 | 153.248 | 208.446 | 141.615 | 92.4% | 4 | III | None | Craniotomy |
6 | M | 35.2 | MTLE | OXC, LTG, VPA | 1 | 10 | 3259.42 | 3764.87 | 3066.86 | 94.1% | 4 | I | None | None |
7 | F | 24.6 | MTLE | LEV, VPA | 1 | 20 | 3046.08 | 3310.68 | 2788.99 | 91.6% | 4 | IV | Visual field defect | Craniotomy |
8 | M | 15.1 | MTLE | LTG, OXC | 1 | 20 | 3516 | 3548.85 | 3204.59 | 91.1% | 6 | IV | None | None |
9 | M | 3 | HH | TPM | 1 | 5 | 349.536 | 463.269 | 324.989 | 93% | 5 | IV | None | RF-TC |
10 | M | 3.3 | HH | LEV, VPA, LCM | 1 | 5 | 1307.26 | 1515.17 | 1243.11 | 95.1% | 5 | III | None | RF-TC |
11 | M | 3.2 | HH | VPA | 1 | 5 | 1845.45 | 2141.41 | 1695.22 | 91.9% | 5 | I | None | None |
12 | M | 36.9 | FCD | CBZ, LTG, VPA, TPM | 1 | 2 | 4698.78 | 6582.23 | 4310.23 | 91.7% | 7 | I | Intracranial hemorrhage | Craniotomy |
13 | M | 3.11 | TSC | OXC, VPA | 2 | 5 | 5627.49 | 6212.61 | 5323.48 | 94.6% | 4 | I | None | Craniotomy |
14 | F | 61.4 | CM | CBZ | 1 | 5 | 1747.63 | 2130.37 | 1683.97 | 96.4% | 4 | I | None | None |
15 | F | 10.2 | FCD | LEV, OXC, LCM, PB | 1 | 10 | 6033.22 | 7416.95 | 5513.87 | 91.4% | 6 | II | None | RF-TC |
16 | F | 30.5 | LGS(Corpus callosotomy) | TPM, CZP, LEV | 1 | 10 | 2404.08 | 3353.268 | 2187.895 | 91.0% | 7 | IV | None | None |
17 | M | 30.6 | MTLE | OXC | 1 | 5 | 4337.1 | 4603.68 | 3984 | 91.9% | 4 | IV | None | RF-TC |
18 | F | 29.11 | MTLE | TPM, VPA, LTG | 1 | 5 | 1942.65 | 2465.73 | 1765.28 | 90.9% | 6 | II | None | None |
19 | M | 16.6 | FCD | VPA, LEV, PB | 1 | 5 | 3049.28 | 3755.74 | 2795.58 | 91.7% | 6 | III | Temporary decrease in muscle strength | RF-TC |